Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by denvermckeeon Mar 02, 2018 8:50am
186 Views
Post# 27650152

Not profitable

Not profitable  . During the three-month period ended December 31, 2017, the Company generated income of $164,446. During the nine-month period ended December 31, 2017, the Company’s cash from operations did not generate positive cash flows, the Company had incurred a net loss of $10,808,503 and the Company had an accumulated deficit of $24,684,576. Although the Company did not generate positive cash flows, the loss from operations during the quarter ended December 31, 2017 was $1,588,794. Of that, $1,934,344 was attributed to non-cash stock-based compensation from the issuance of stock options during the period. The Company’s continuation as a going concern is dependent upon the Company’s ability to continually grow its revenues and attain profitable operations and generate funds from and/or raise equity capital or borrowings sufficient to meet current and future obligations..
Bullboard Posts